Study in Patients Suffering From Heartburn and Backward Flow of Stomach Liquid Into the Esophagus
Status:
Completed
Trial end date:
2013-05-03
Target enrollment:
Participant gender:
Summary
In this study researchers want to learn more about the effectiveness of Iberogast® in
patients with irritable stomach and concomitant chronic or recurrent heartburn and backward
flow of stomach liquid into the esophagus. 60 patients in the age range from 18 - 80 year
will be treated over 4 weeks with Iberogast® or placebo - an inactive substance which looks
identical to Iberogast®. Patients completed diaries will provide researchers with detailed
information on the change of stomach and intestinal symptoms during the treatment period. In
addition information on the acidity of the esophagus and stomach liquid will be collected.